PhaseBio Pharmaceuticals Inc·4

Mar 1, 5:07 PM ET

York Michael 4

4 · PhaseBio Pharmaceuticals Inc · Filed Mar 1, 2019

Insider Transaction Report

Form 4
Period: 2019-02-27
York Michael
VP, Corporate Development
Transactions
  • Award

    Employee Stock Option (right to buy)

    2019-02-27+45,00045,000 total
    Exercise: $3.15Exp: 2029-02-27Common Stock (45,000 underlying)
Footnotes (1)
  • [F1]The shares subject to the option shall vest in equal monthly installments over 48 months from February 27, 2019, subject to the reporting person's continued service through each such date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION